Home › Stocks › LIMN › Changes

Who bought & sold LIMN (Q3 2026)

Funds holding (Q3 2026)10
New positions4
Added1
Reduced5
Exited8

As of Q3 2026, 10 institutional funds reported holding LIMN (LIMINATUS PHARMA INC.): 4 opened new positions, 1 added, 5 trimmed and 8 exited entirely. 13F filings are quarter-end snapshots of positioning, not intra-quarter trades.

New positions (4)

Fund Shares Value Weight
JANE STREET GROUP, LLC New 14.95K $55.76K —
Morgan Stanley New 1.94K $7.22K —
JPMorgan Chase & Co New 137 $536 —
Cheviot Value Management, LLC New 100 $373 —

Added to positions (1)

Fund Shares Value Weight Change
BlackRock Inc 934 $3.48K — +621 sh (+198.4%)

Reduced positions (5)

Fund Shares Value Weight Change
Geode Capital Management 41.21K $153.70K — -97.21K sh (-70.2%)
VANGUARD CAPITAL MANAGEMENT LLC 1.01K $3.76K — -49.43K sh (-98.0%)
VANGUARD FIDUCIARY TRUST CO 460 $1.72K — -22.52K sh (-98.0%)
UBS Group AG 1.20K $4.48K — -15.53K sh (-92.8%)
Tower Research Capital LLC (TRC) 87 $325 — -7.01K sh (-98.8%)

Exited positions (8)

Held in the prior quarter but not reported in the latest filing.

Fund Shares Value Weight
Cygnus Capital Advisors, LLC Exited 329.33K $36.00K 0.0
XTX Topco Ltd Exited 221.84K $24.49K —
GEODE CAPITAL MANAGEMENT, LLC Exited 138.42K $15.28K —
Citadel Advisors Exited 56.09K $6.19K —
Goldman Sachs Group Exited 40.22K $4.44K —
StoneX Group Inc. Exited 26.06K $3.93K —
Vanguard Personalized Indexing Management, LLC Exited 13.15K $1.45K —
BARCLAYS PLC Exited 4.29K $474 —